Gabelli Healthcare & WellnessRx Trust (GRX) reported insider activity by a 10% owner. An affiliated holder purchased common stock on two consecutive days, indicating additional accumulation.
On 10/16/2025, the holder bought 3,520 shares at $9.18. On 10/17/2025, they bought 5,816 shares at $9.20. Following these transactions, the filer reported 2,060,371 shares beneficially owned on an indirect basis. The filing is signed for Saba Capital Management, L.P. by Zachary Gindes, with Boaz Weinstein also listed.
Sit Investment Associates, Inc. and its subsidiary Sit Fixed Income Advisors II, LLC reported shared beneficial ownership of 833,756 shares of The Gabelli Healthcare & WellnessRx Trust common stock, representing 5.4% of the class based on 15,447,824 shares outstanding as of June 30, 2025. The filing states the shares are held in client accounts managed by the advisers and that the advisers disclaim beneficial ownership under Rule 13d-4. Both filers report 0 sole voting and dispositive power and 833,756 shares of shared voting and dispositive power. The filing includes a joint filing agreement and a certification by Paul E. Rasmussen as Vice President.
Saba Capital Management, L.P. reported two open-market purchases of Gabelli Healthcare & WellnessRx Trust (GRX) common stock on 09/11/2025 and 09/12/2025 at $9.43 per share. The first purchase was 6,147 shares, bringing indirect beneficial ownership to 2,043,303 shares; the second added 7,732 shares, increasing indirect ownership to 2,051,035. The filing lists the reporting person as a Director and a 10% owner and is signed by Zachary Gindes and Boaz Weinstein on 09/15/2025.
Saba Capital Management, L.P. and reporting person Boaz Weinstein reported an acquisition of Common Stock of Gabelli Healthcare & WellnessRx Trust (GRX). On 08/25/2025 they purchased 11,330 shares at $9.48 per share, and the filing shows 2,037,156 shares beneficially owned indirectly following the transaction. The Form 4 is signed and dated 08/26/2025 by Saba Capital and Boaz Weinstein.
The filing reports that Saba Capital Management, L.P. and Boaz Weinstein, both identified as a director and 10% owner, purchased 19,101 shares of Gabelli Healthcare & WellnessRx Trust (GRX) on 08/21/2025 at a price of $9.43 per share. After the transaction, the reporting persons are shown as beneficially owning 2,025,826 shares indirectly. The Form 4 reflects a routine insider purchase disclosed under Section 16.